China Reports 2.7 Million Adverse Drug Reactions in 2025
China's National Medical Products Administration released its 2025 annual report on adverse drug reaction monitoring. The 2025 annual report from the National Medical Products Administration confirms over 2.7 million reports, showing a year-on-year increase. Since the establishment of the national monitoring network, a cumulative 28.6 million reports have been recorded. Tian Chunhua, head of the National Drug Adverse Reaction Monitoring Center, stated the increase indicates a more robust monitoring system. The monitoring aims to detect and control safety risks to protect public health.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
CNR Voice of China
“记者今天从国家药监局获悉，国家药品不良反应监测2025年度报告最新发布，报告显示，我国2025年收到270多万份药品不良反应报告，同比增”
CNR Voice of China
“报告显示 我国2025年收到270多万份 药品不良反应报告 同比增”
CNR Voice of China
“国家药监局获悉 国家药品不良反应监测2025年度报告最新发布 报告显示 我国2025年收到270多万份 药品不良反应报告”
CNR Voice of China
“The report shows that in 2025, our country received more than 2.7 million drug adverse reaction reports, an increase of more than 5% over the same period last year.”
CNR Voice of China
“新的和严重的不不良反应 一直是我们重要坚持的内容 同时新的 严重的不良反应的构成笔 是衡量我们这个整个监测工作的 总体质量和可力运性的重要指标之一”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade